A comparative proteomic study of sera in paediatric systemic lupus erythematosus patients and in healthy controls using MALDI-TOF-TOF and LC MS-A pilot study

Pediatric Rheumatology

Volumn 10, Issue , 2012, Pages

  Rana, Anita ^a   Minz, Ranjana W ^a   Aggarwal, Ritu ^a   Sharma, Sadhna ^a   Pasricha, Neelam ^a   Anand, Shashi ^a   Singh, Surjit ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Apolipoprotein A1; Leiomodin 2; Liquid chromatography mass spectrometry; Matrix assisted laser desorption ionization time of flight; Paediatric systemic lupus erythematosus; Retinol binding protein; Transthyretin; Two dimensional poly acryl amide gel electrophoresis

Indexed keywords

APOLIPOPROTEIN A1; COMPLEMENT COMPONENT C3C; CYTOKERATIN 1; EPIDERMAL CYTOKERATIN 2; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE II; IMMUNOGLOBULIN KAPPA CHAIN; LEIOMODIN 2; PREALBUMIN; RETINOL BINDING PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD SAMPLING; CAMPATH ANTIBODY ANTIGEN COMPLEX; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DOWN REGULATION; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84865056578     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/1546-0096-10-24     Document Type: Article

References (38)

1. Cao MY, Dupriez VJ, Rider MH, Deggouj N, Gersdorff MC, Rousseau GG, Tomasi JP. Myelin protein Po as a potential autoantigen in autoimmune inner ear disease. FASEB J 1996, 10(14):1635-1640.
2. Lee KH, Chung HS, Kim HS, Oh SH, Ha MK, Baik JH, Lee S, Bang D. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease. Arthritis Rheum 2003, 48(7):2025-2035. 10.1002/art.11074, 12847697.
3. Xiang Y, Kato T. Use of proteomics in analysis of autoimmune diseases. Lupus 2006, 15(7):431-435. 10.1191/0961203306lu2329oa, 16898178.
4. Lambrecht S, Tilleman K, Elewaut D, Deforce D. Proteomics in rheumatology: The beginning of a fairy tale?. Proteomics Clin Appl 2008, 2(3):411-419. 10.1002/prca.200780084, 21136842.
5. Dai Y, Hu C, Huang Y, Huang H, Liu J, Lv T. A proteomic study of peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 2008, 17(9):799-804. 10.1177/0961203308089444, 18755861.
6. Jin EH, Shim SC, Kim HG, Chae SC, Chung HT. Polymorphisms of COTL1 gene identified by proteomic approach and their association with autoimmune disorders. Exp Mol Med 2009, 41(5):354-361. 10.3858/emm.2009.41.5.040, 2701985, 19307756.
7. Kinloch A, Tatzer V, Wait R, Peston D, Lundberg K, Donatien P, Moyes D, Taylor PC, Venables PJ. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 2005, 7(6):R1421-R1429. 10.1186/ar1845, 1297593, 16277695.
8. Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4(12):3665-3685. 10.1002/pmic.200401031, 15543535.
9. Tambor V, Fucikova A, Lenco J, Kacerovsky M, Rehacek V, Stulik J, Pudil R. Application of proteomics in biomarker discovery: a primer for the clinician. Physiol Res 2010, 59(4):471-497.
10. Futcher B, Latter GI, Monardo P, McLaughlin CS, Garrels JI. A sampling of the yeast proteome. Mol Cell Biol 1999, 19(11):7357-7368. 84729, 10523624.
11. Varshavsky A. The N-end rule: functions, mysteries, uses. Proc Natl Acad Sci U S A 1996, 93(22):12142-12149. 10.1073/pnas.93.22.12142, 37957, 8901547.
12. Jackson RJ, Standart N. Do the poly(A) tail and 3′ untranslated region control mRNA translation?. Cell 1990, 62(1):15-24. 10.1016/0092-8674(90)90235-7, 1973075.
13. Sheets MD, Fox CA, Hunt T, Vande Woude G, Wickens M. The 3′-untranslated regions of c-mos and cyclin mRNAs stimulate translation by regulating cytoplasmic polyadenylation. Genes Dev 1994, 8(8):926-938. 10.1101/gad.8.8.926, 7926777.
14. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999, 10(3):387-398. 10.1016/S1074-7613(00)80038-2, 10204494.
15. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25(11):1271-1277. 10.1002/art.1780251101, 7138600.
16. Gladman DD, Urowitz MB, Kagal A, Hallett D. Accurately describing changes in disease activity in Systemic Lupus Erythematosus. J Rheumatol 2000, 27(2):377-379.
17. Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS, Mische SM. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 1999, 20(3):601-605. 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6, 10217175.
18. Knepper MA. Proteomics and the kidney. J Am Soc Nephrol 2002, 13(5):1398-1408. 10.1097/01.ASN.0000014782.37591.C7, 11961030.
19. Oates JC, Varghese S, Bland AM, Taylor TP, Self SE, Stanislaus R, Almeida JS, Arthur JM. Prediction of urinary protein markers in lupus nephritis. Kidney Int 2005, 68(6):2588-2592. 10.1111/j.1523-1755.2005.00730.x, 2667626, 16316334.
20. Fang S, Zeng F, Guo Q. Comparative proteomics analysis of cytokeratin and involucrin expression in lesions from patients with systemic lupus erythematosus. Acta Biochim Biophys Sin (Shanghai) 2008, 40(12):989-995.
21. Zhang X, Jin M, Wu H, Nadasdy T, Nadasdy G, Harris N, Green-Church K, Nagaraja H, Birmingham DJ, Yu CY, et al. Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int 2008, 74(6):799-807. 10.1038/ki.2008.316, 2614389, 18596723.
22. Stephens P, Edkins S, Davies H, Greenman C, Cox C, Hunter C, Bignell G, Teague J, Smith R, Stevens C, et al. A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat Genet 2005, 37(6):590-592. 10.1038/ng1571, 15908952.
23. Dillon SC, Taylor GM, Shah V. Diagnostic value of urinary retinol-binding protein in childhood nephrotic syndrome. Pediatr Nephrol 1998, 12(8):643-647. 10.1007/s004670050519, 9811386.
24. Guy JM, Brammah TB, Holt L, Bernstein RM, McMurray JR, Tieszen K, Cooper RG. Urinary excretion of albumin and retinol binding protein in systemic lupus erythematosus. Ann Clin Biochem 1997, 34(Pt 6):668-674.
25. Sesso R, Rettori R, Nishida S, Sato E, Ajzen H, Pereira AB. Assessment of lupus nephritis activity using urinary retinol-binding protein. Nephrol Dial Transplant 1994, 9(4):367-371.
26. Smith GC, Winterborn MH, Taylor CM, Lawson N, Guy M. Assessment of retinol-binding protein excretion in normal children. Pediatr Nephrol 1994, 8(2):148-150. 10.1007/BF00865463, 8018490.
27. Conley CA, Fritz-Six KL, Almenar-Queralt A, Fowler VM. Leiomodins: larger members of the tropomodulin (Tmod) gene family. Genomics 2001, 73(2):127-139. 10.1006/geno.2000.6501, 11318603.
28. Chereau D, Boczkowska M, Skwarek-Maruszewska A, Fujiwara I, Hayes DB, Rebowski G, Lappalainen P, Pollard TD, Dominguez R. Leiomodin is an actin filament nucleator in muscle cells. Science 2008, 320(5873):239-243. 10.1126/science.1155313, 2845909, 18403713.
29. Tsukada T, Pappas CT, Moroz N, Antin PB, Kostyukova AS, Gregorio CC. Leiomodin-2 is an antagonist of tropomodulin-1 at the pointed end of the thin filaments in cardiac muscle. J Cell Sci 2010, 123(Pt 18):3136-3145. 2931607, 20736303.
30. Zheng W, Lu YM, Lu GY, Zhao Q, Cheung O, Blaner WS. Transthyretin, thyroxine, and retinol-binding protein in human cerebrospinal fluid: effect of lead exposure. Toxicol Sci 2001, 61(1):107-114. 10.1093/toxsci/61.1.107, 11294981.
31. Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 2003, 10(3):160-184. 10.3109/13506120308998998, 14640030.
32. Ingenbleek Y, Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 1994, 14:495-533. 10.1146/annurev.nu.14.070194.002431, 7946531.
33. Rudin DO. The choroid plexus and system disease in mental illness. III. The exogenous peptide hypothesis of mental illness. Biol Psychiatry 1981, 16(5):489-512.
34. Jacobson DR, Reveille JD, Buxbaum JN. Frequency and genetic background of the position 122 (Val--Ile) variant transthyretin gene in the black population. Am J Hum Genet 1991, 49(1):192-198. 1683217, 2063870.
35. Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, Tsutsumi A, Tatsuya A, Dayer JM, Roux-Lombard P, Fontao L, Kallenberg CG, et al. Autoantibodies against protective molecules-C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N Y Acad Sci 2007, 1108:227-239. 10.1196/annals.1422.025, 17899624.
36. Burger D, Dayer JM. High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?. Autoimmun Rev 2002, 1(1-2):111-117.
37. Zhang B, Pu S, Li B, Ying J, Song XW, Gao C. Comparison of serum apolipoprotein A-I between Chinese multiple sclerosis and other related autoimmune disease. Lipids Health Dis 2010, 9:34. 10.1186/1476-511X-9-34, 2860353, 20350318.
38. McMahon M, Grossman J, FitzGerald J, Dahlin-Lee E, Wallace DJ, Thong BY, Badsha H, Kalunian K, Charles C, Navab M, et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006, 54(8):2541-2549. 10.1002/art.21976, 16868975.